These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6302395)

  • 41. Physicochemical and functional modifications induced by obesity on human erythrocyte membranes.
    Faloia E; Garrapa GG; Martarelli D; Camilloni MA; Lucarelli G; Staffolani R; Mantero F; Curatola G; Mazzanti L
    Eur J Clin Invest; 1999 May; 29(5):432-7. PubMed ID: 10354200
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Abnormalities of sodium transport by sodium, potassium-activated adenosine triphosphatase in erythrocytes from obese children.
    Dianzani I; Boero R; Guarena C; Urbino A; Corda G; Quarello F; Cerutti F
    Clin Sci (Lond); 1988 Jan; 74(1):57-61. PubMed ID: 2827939
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of diet on ouabain binding to erythrocytes from obese subjects.
    Ash KO; Smith JB; Kemp JW; Lynch MB; Moody FG; Raymond JL; McKnight MR; Williams RR
    Clin Physiol Biochem; 1983; 1(6):293-9. PubMed ID: 6094078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Erythrocyte thermogenesis in hyperthyroid patients: microcalorimetric investigation of sodium/potassium pump and cell metabolism.
    Monti M; Hedner P; Ikomi-Kumm J; Valdemarsson S
    Metabolism; 1987 Feb; 36(2):155-9. PubMed ID: 3027499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of hemodialysis on the erythrocyte sodium, potassium adenosine triphosphatase activity in children with chronic renal failure].
    Levanovich VV; Rustamov FA; Kornilov AM; Chirovich M
    Pediatriia; 1991; (7):78-82. PubMed ID: 1661399
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.
    Forst T; De La Tour DD; Kunt T; Pfützner A; Goitom K; Pohlmann T; Schneider S; Johansson BL; Wahren J; Löbig M; Engelbach M; Beyer J; Vague P
    Clin Sci (Lond); 2000 Mar; 98(3):283-90. PubMed ID: 10677386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal adaptation to potassium in the adrenalectomized rabbit. Role of distal tubular sodium-potassium adenosine triphosphatase.
    Garg LC; Narang N
    J Clin Invest; 1985 Sep; 76(3):1065-70. PubMed ID: 2995442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Animal and human tissue Na,K-ATPase in normal and insulin-resistant states: regulation, behaviour and interpretative hypothesis on NEFA effects.
    Iannello S; Milazzo P; Belfiore F
    Obes Rev; 2007 May; 8(3):231-51. PubMed ID: 17444965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. No correlation between erythrocyte Na,K-ATPase activity and resting metabolic rate in humans.
    Welle S
    J Clin Endocrinol Metab; 1989 Oct; 69(4):914-6. PubMed ID: 2550512
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Electrolytes and NA(+)-K(+)-ATPase: potential risk factors for the development of diabetic nephropathy.
    Shahid SM; Mahboob T
    Pak J Pharm Sci; 2008 Apr; 21(2):172-9. PubMed ID: 18390448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in Na,K-adenosine triphosphatase (ATPase) concentration and Na,K-ATPase-dependent adenosine triphosphate turnover in human erythrocytes in diabetes.
    Garner MH
    Metabolism; 1996 Aug; 45(8):927-34. PubMed ID: 8769346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduced Na(+), K(+)-ATPase activity in erythrocyte membranes from patients with phenylketonuria.
    Bedin M; Estrella CH; Ponzi D; Duarte DV; Dutra-Filho CS; Wyse AT; Wajner M; Wannmacher CM
    Pediatr Res; 2001 Jul; 50(1):56-60. PubMed ID: 11420419
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduction of erythrocyte (Na(+)-K+)ATPase activity in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.
    Mimura M; Makino H; Kanatsuka A; Asai T; Yoshida S
    Horm Metab Res; 1994 Jan; 26(1):33-8. PubMed ID: 8150421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibitory Effect of Fluoride on Na+,K+ ATPase Activity in Human Erythrocyte Membrane.
    A S; G M
    Biol Trace Elem Res; 2015 Dec; 168(2):340-8. PubMed ID: 25957596
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Incorporation of Na,K-ATPase into human erythrocyte membranes using liposomes].
    Stel'makh LN; Rozhmanova OM; Lishko VK
    Biokhimiia; 1984 Mar; 49(3):460-3. PubMed ID: 6326865
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Erythrocyte sodium-potassium-ATPase and obesity.
    N Engl J Med; 1982 Apr; 306(13):807-10. PubMed ID: 6278306
    [No Abstract]   [Full Text] [Related]  

  • 57. Erythrocyte Na+,K(+)-ATPase properties and adenylate energy charge in normotensives and in essential hypertensives.
    Canestrari F; Galli F; Boschi S; Albertini MC; Gheller G; De Crescentini S; Bossú M
    Clin Chim Acta; 1994 Jan; 224(2):167-79. PubMed ID: 8004787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of oxidative stress on the erythrocyte Na+,K+ ATPase activity in female hyperthyroid patients.
    Konukoglu D; Yelke HK; Hatemi H; Sabuncu T
    J Toxicol Environ Health A; 2001 Jun; 63(4):289-95. PubMed ID: 11437061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The activity and properties of Na,K-ATPase in the erythrocytes and the Na-pump inhibitor in the plasma of subjects with borderline arterial hypertension].
    Maslova MN; Ogorodnikova LE; Titkov IuS
    Fiziol Zh SSSR Im I M Sechenova; 1991 Sep; 77(9):232-7. PubMed ID: 1666609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endogenous plasma Na,K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction.
    Bagrov AYa ; Fedorova OV; Maslova MN; Roukoyatkina NI; Ukhanova MV; Zhabko EP
    Cardiovasc Res; 1991 May; 25(5):371-7. PubMed ID: 1649699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.